These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37538110)

  • 21. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.
    Duan X; Zhou G; Han X; Ren J; Zheng C; Liang H; Feng G
    Acta Radiol; 2015 Jan; 56(1):87-96. PubMed ID: 24425792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers.
    Zhang S; Huang C; Li Z; Yang Y; Bao T; Chen H; Zou Y; Song L
    Drug Deliv; 2017 Nov; 24(1):1011-1017. PubMed ID: 28660787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
    Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer.
    Wang W; Li F; Gan P; Li B; Li S
    Front Surg; 2022; 9():981116. PubMed ID: 36117819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients.
    Peng N; Mao L; Tao Y; Xiao K; Yuan G; He S
    World J Surg Oncol; 2022 Aug; 20(1):254. PubMed ID: 35941634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of total liver perfusion imaging of CT for efficacy of transcatheter arterial chemoembolization combined with apatinib on rabbit VX2 liver tumors].
    Liu X; Deng L; Guo R; Liang Q; Liu S; Hu P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):477-484. PubMed ID: 31303609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.
    Britten CD; Gomes AS; Wainberg ZA; Elashoff D; Amado R; Xin Y; Busuttil RW; Slamon DJ; Finn RS
    BMC Cancer; 2012 Jan; 12():16. PubMed ID: 22244160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphology, Loadability, and Releasing Profiles of CalliSpheres Microspheres in Delivering Oxaliplatin: An
    Han X; Chen Q; Sun Y; Han L; Sha X
    Technol Cancer Res Treat; 2019; 18():1533033819877989. PubMed ID: 31630671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
    Li J; Wang N; Shi C; Liu Q; Song J; Ye X
    J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Chen Q; Shu L; Sun Y; Guo P; Wang D; Sha X
    Cancer Biother Radiopharm; 2023 Oct; 38(8):512-520. PubMed ID: 33493417
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
    Elkhadragy L; Khabbaz RC; Muchiri RN; Totura WM; Samuelson JP; Whiteley HE; van Breemen RB; Lokken RP; Gaba RC
    J Vasc Interv Radiol; 2022 Oct; 33(10):1213-1221.e5. PubMed ID: 35850455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
    Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
    In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization using CalliSpheres in treating huge hepatocellular carcinoma patients.
    Wang Z; Mu K; Lv Y; Zhao L; Li B; Hao Y; Wang N
    Ir J Med Sci; 2022 Dec; 191(6):2493-2499. PubMed ID: 35064533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma.
    Bi Y; Ren K; Ren J; Ma J; Han X
    Front Pharmacol; 2022; 13():923585. PubMed ID: 36034827
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.
    Berz AM; Santana JG; Iseke S; Gross M; Pekurovsky V; Laage Gaupp F; Savic LJ; Borde T; Gottwald LA; Boustani AM; Gebauer B; Lin M; Zhang X; Schlachter T; Madoff DC; Chapiro J
    J Vasc Interv Radiol; 2022 Jul; 33(7):764-774.e4. PubMed ID: 35346859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of temperature-sensitive liquid embolic agent loaded with oxaliplatin in the TACE procedure for rabbit VX2 gastric cancer.
    Li Y; Ge X; Li Z; Zhou Z; Wu K; Li Y; Ji T; Wang C; Guo K; Ren J; Han X; Ren K
    Drug Deliv Transl Res; 2024 Mar; 14(3):705-717. PubMed ID: 37668861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
    Bi Y; Shi X; Ren J; Yi M; Han X; Song M
    BMC Gastroenterol; 2021 May; 21(1):231. PubMed ID: 34020608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoscale CaO
    Wang Y; He X; Zhou C; Bai Y; Li T; Liu J; Ju S; Wang C; Xiang G; Xiong B
    Acta Biomater; 2022 Dec; 154():536-548. PubMed ID: 36241014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
    Zinner RG; Obasaju CK; Spigel DR; Weaver RW; Beck JT; Waterhouse DM; Modiano MR; Hrinczenko B; Nikolinakos PG; Liu J; Koustenis AG; Winfree KB; Melemed SA; Guba SC; Ortuzar WI; Desaiah D; Treat JA; Govindan R; Ross HJ
    J Thorac Oncol; 2015 Jan; 10(1):134-42. PubMed ID: 25371077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study.
    Zhang X; Zhou J; Zhu DD; Huang J; Sun JH; Li TF; Shi CS; Sun ZC; Hou QM; Peng ZY; Yu WQ; Ji JS; Gu WJ; Zhou GH; Xie XX; Guo XH; Cao GH; Yu ZH; Xu HH; Fang J; Ying SH; Hu WH; Ji WB; Han J; Wu X; Zheng JP; Luo J; Chen YT; Hu TY; Li L; Hu HJ; Du HJ; Shao GL
    Clin Transl Oncol; 2019 Feb; 21(2):167-177. PubMed ID: 30003530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.